nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—CBR1—Doxorubicin—stomach cancer	0.193	0.321	CbGbCtD
Haloperidol—UGT1A9—Irinotecan—stomach cancer	0.0892	0.148	CbGbCtD
Haloperidol—ABCB1—Mitomycin—stomach cancer	0.0564	0.0936	CbGbCtD
Haloperidol—CYP3A7—Irinotecan—stomach cancer	0.0296	0.0492	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.0296	0.0492	CbGbCtD
Haloperidol—CYP2C9—Capecitabine—stomach cancer	0.0241	0.0401	CbGbCtD
Haloperidol—CYP3A5—Irinotecan—stomach cancer	0.0222	0.0369	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.0217	0.0361	CbGbCtD
Haloperidol—CYP3A7—Docetaxel—stomach cancer	0.0217	0.0361	CbGbCtD
Haloperidol—CYP3A5—Docetaxel—stomach cancer	0.0163	0.027	CbGbCtD
Haloperidol—CYP1A2—Fluorouracil—stomach cancer	0.0159	0.0264	CbGbCtD
Haloperidol—ABCB1—Irinotecan—stomach cancer	0.0145	0.024	CbGbCtD
Haloperidol—CYP2C9—Fluorouracil—stomach cancer	0.0143	0.0238	CbGbCtD
Haloperidol—ABCB1—Docetaxel—stomach cancer	0.0106	0.0176	CbGbCtD
Haloperidol—CYP3A4—Irinotecan—stomach cancer	0.00867	0.0144	CbGbCtD
Haloperidol—ABCB1—Doxorubicin—stomach cancer	0.0079	0.0131	CbGbCtD
Haloperidol—ABCB1—Methotrexate—stomach cancer	0.00766	0.0127	CbGbCtD
Haloperidol—CYP2D6—Doxorubicin—stomach cancer	0.00745	0.0124	CbGbCtD
Haloperidol—CYP3A4—Docetaxel—stomach cancer	0.00635	0.0105	CbGbCtD
Haloperidol—HTR2A—myenteric nerve plexus—stomach cancer	0.00499	0.0664	CbGeAlD
Haloperidol—CYP3A4—Doxorubicin—stomach cancer	0.00474	0.00786	CbGbCtD
Haloperidol—HTR2A—vagus nerve—stomach cancer	0.00333	0.0443	CbGeAlD
Haloperidol—HTR2A—vein—stomach cancer	0.00322	0.0428	CbGeAlD
Haloperidol—EBP—endocrine gland—stomach cancer	0.00217	0.0289	CbGeAlD
Haloperidol—HTR1B—blood vessel—stomach cancer	0.00212	0.0283	CbGeAlD
Haloperidol—HTR1D—blood vessel—stomach cancer	0.00206	0.0274	CbGeAlD
Haloperidol—EBP—liver—stomach cancer	0.00196	0.0261	CbGeAlD
Haloperidol—UGT1A9—digestive system—stomach cancer	0.00159	0.0212	CbGeAlD
Haloperidol—H1F0—hematopoietic system—stomach cancer	0.00141	0.0188	CbGeAlD
Haloperidol—GRIN2B—endocrine gland—stomach cancer	0.00134	0.0178	CbGeAlD
Haloperidol—UGT1A9—endocrine gland—stomach cancer	0.00132	0.0175	CbGeAlD
Haloperidol—H1F0—smooth muscle tissue—stomach cancer	0.00124	0.0166	CbGeAlD
Haloperidol—CBR1—lymphoid tissue—stomach cancer	0.00121	0.0162	CbGeAlD
Haloperidol—CBR1—digestive system—stomach cancer	0.0012	0.016	CbGeAlD
Haloperidol—UGT1A9—liver—stomach cancer	0.00119	0.0158	CbGeAlD
Haloperidol—H1F0—pancreas—stomach cancer	0.00115	0.0153	CbGeAlD
Haloperidol—CBR1—bone marrow—stomach cancer	0.00111	0.0147	CbGeAlD
Haloperidol—CYP3A7—endocrine gland—stomach cancer	0.0011	0.0146	CbGeAlD
Haloperidol—HTR2A—blood vessel—stomach cancer	0.00102	0.0136	CbGeAlD
Haloperidol—H1F0—lymphoid tissue—stomach cancer	0.000995	0.0132	CbGeAlD
Haloperidol—CBR1—endocrine gland—stomach cancer	0.000991	0.0132	CbGeAlD
Haloperidol—CYP3A7—liver—stomach cancer	0.000988	0.0131	CbGeAlD
Haloperidol—H1F0—digestive system—stomach cancer	0.000983	0.0131	CbGeAlD
Haloperidol—H1F0—bone marrow—stomach cancer	0.000906	0.0121	CbGeAlD
Haloperidol—SIGMAR1—smooth muscle tissue—stomach cancer	0.000899	0.012	CbGeAlD
Haloperidol—HTR2B—smooth muscle tissue—stomach cancer	0.000897	0.0119	CbGeAlD
Haloperidol—CBR1—liver—stomach cancer	0.000894	0.0119	CbGeAlD
Haloperidol—CYP2C19—hematopoietic system—stomach cancer	0.000852	0.0113	CbGeAlD
Haloperidol—CYP3A7-CYP3A51P—liver—stomach cancer	0.00084	0.0112	CbGeAlD
Haloperidol—SIGMAR1—pancreas—stomach cancer	0.000831	0.0111	CbGeAlD
Haloperidol—KCNH2—hematopoietic system—stomach cancer	0.000812	0.0108	CbGeAlD
Haloperidol—H1F0—endocrine gland—stomach cancer	0.000812	0.0108	CbGeAlD
Haloperidol—H1F0—liver—stomach cancer	0.000732	0.00974	CbGeAlD
Haloperidol—HTR2B—digestive system—stomach cancer	0.000708	0.00942	CbGeAlD
Haloperidol—CYP1A2—hematopoietic system—stomach cancer	0.000696	0.00925	CbGeAlD
Haloperidol—CYP1A1—hematopoietic system—stomach cancer	0.000686	0.00913	CbGeAlD
Haloperidol—CBR1—lymph node—stomach cancer	0.000685	0.00912	CbGeAlD
Haloperidol—Sertindole—HTR1A—stomach cancer	0.000672	0.367	CrCbGaD
Haloperidol—CYP3A5—hematopoietic system—stomach cancer	0.000671	0.00893	CbGeAlD
Haloperidol—ABCB1—blood vessel—stomach cancer	0.000669	0.0089	CbGeAlD
Haloperidol—CYP2C9—hematopoietic system—stomach cancer	0.00066	0.00878	CbGeAlD
Haloperidol—SIGMAR1—bone marrow—stomach cancer	0.000654	0.00871	CbGeAlD
Haloperidol—HRH1—hematopoietic system—stomach cancer	0.000651	0.00866	CbGeAlD
Haloperidol—HTR1B—endocrine gland—stomach cancer	0.00065	0.00864	CbGeAlD
Haloperidol—CYP1A1—epithelium—stomach cancer	0.000627	0.00834	CbGeAlD
Haloperidol—Fluspirilene—ADRB1—stomach cancer	0.000612	0.334	CrCbGaD
Haloperidol—HRH1—epithelium—stomach cancer	0.000595	0.00792	CbGeAlD
Haloperidol—CYP2C19—digestive system—stomach cancer	0.000592	0.00788	CbGeAlD
Haloperidol—HRH1—smooth muscle tissue—stomach cancer	0.000574	0.00763	CbGeAlD
Haloperidol—H1F0—lymph node—stomach cancer	0.000561	0.00747	CbGeAlD
Haloperidol—Fluspirilene—HTR1A—stomach cancer	0.000547	0.299	CrCbGaD
Haloperidol—CYP3A5—pancreas—stomach cancer	0.000546	0.00727	CbGeAlD
Haloperidol—HTR2A—hematopoietic system—stomach cancer	0.000544	0.00724	CbGeAlD
Haloperidol—SIGMAR1—liver—stomach cancer	0.000529	0.00704	CbGeAlD
Haloperidol—KCNH2—bone marrow—stomach cancer	0.000521	0.00693	CbGeAlD
Haloperidol—CYP3A4—hematopoietic system—stomach cancer	0.000503	0.0067	CbGeAlD
Haloperidol—HTR2A—epithelium—stomach cancer	0.000497	0.00661	CbGeAlD
Haloperidol—CYP2D6—hematopoietic system—stomach cancer	0.000495	0.00659	CbGeAlD
Haloperidol—CYP2C19—endocrine gland—stomach cancer	0.000489	0.00651	CbGeAlD
Haloperidol—CYP1A2—digestive system—stomach cancer	0.000484	0.00644	CbGeAlD
Haloperidol—HTR2A—smooth muscle tissue—stomach cancer	0.000479	0.00637	CbGeAlD
Haloperidol—CYP1A1—digestive system—stomach cancer	0.000477	0.00635	CbGeAlD
Haloperidol—DRD2—endocrine gland—stomach cancer	0.000474	0.0063	CbGeAlD
Haloperidol—KCNH2—endocrine gland—stomach cancer	0.000467	0.00621	CbGeAlD
Haloperidol—CYP3A5—digestive system—stomach cancer	0.000467	0.00621	CbGeAlD
Haloperidol—CYP2C9—digestive system—stomach cancer	0.000459	0.00611	CbGeAlD
Haloperidol—HRH1—digestive system—stomach cancer	0.000453	0.00602	CbGeAlD
Haloperidol—CYP2C19—liver—stomach cancer	0.000441	0.00587	CbGeAlD
Haloperidol—SIGMAR1—lymph node—stomach cancer	0.000405	0.00539	CbGeAlD
Haloperidol—HTR2B—lymph node—stomach cancer	0.000405	0.00538	CbGeAlD
Haloperidol—CYP1A2—endocrine gland—stomach cancer	0.0004	0.00532	CbGeAlD
Haloperidol—CYP1A1—endocrine gland—stomach cancer	0.000394	0.00525	CbGeAlD
Haloperidol—CYP3A5—endocrine gland—stomach cancer	0.000386	0.00513	CbGeAlD
Haloperidol—CYP2C9—endocrine gland—stomach cancer	0.000379	0.00505	CbGeAlD
Haloperidol—HTR2A—digestive system—stomach cancer	0.000378	0.00503	CbGeAlD
Haloperidol—HRH1—endocrine gland—stomach cancer	0.000374	0.00498	CbGeAlD
Haloperidol—CYP1A2—liver—stomach cancer	0.00036	0.00479	CbGeAlD
Haloperidol—ABCB1—hematopoietic system—stomach cancer	0.000356	0.00474	CbGeAlD
Haloperidol—CYP1A1—liver—stomach cancer	0.000355	0.00473	CbGeAlD
Haloperidol—CYP3A4—digestive system—stomach cancer	0.00035	0.00466	CbGeAlD
Haloperidol—CYP3A5—liver—stomach cancer	0.000348	0.00462	CbGeAlD
Haloperidol—CYP2D6—digestive system—stomach cancer	0.000345	0.00458	CbGeAlD
Haloperidol—CYP2C9—liver—stomach cancer	0.000342	0.00455	CbGeAlD
Haloperidol—ABCB1—epithelium—stomach cancer	0.000326	0.00433	CbGeAlD
Haloperidol—KCNH2—lymph node—stomach cancer	0.000323	0.00429	CbGeAlD
Haloperidol—HTR2A—endocrine gland—stomach cancer	0.000313	0.00416	CbGeAlD
Haloperidol—ABCB1—pancreas—stomach cancer	0.00029	0.00386	CbGeAlD
Haloperidol—CYP3A4—endocrine gland—stomach cancer	0.000289	0.00385	CbGeAlD
Haloperidol—CYP2D6—endocrine gland—stomach cancer	0.000285	0.00379	CbGeAlD
Haloperidol—HTR2A—liver—stomach cancer	0.000282	0.00375	CbGeAlD
Haloperidol—CYP1A1—lymph node—stomach cancer	0.000273	0.00363	CbGeAlD
Haloperidol—CYP3A4—liver—stomach cancer	0.000261	0.00347	CbGeAlD
Haloperidol—HRH1—lymph node—stomach cancer	0.000259	0.00344	CbGeAlD
Haloperidol—CYP2D6—liver—stomach cancer	0.000257	0.00341	CbGeAlD
Haloperidol—ABCB1—lymphoid tissue—stomach cancer	0.000251	0.00334	CbGeAlD
Haloperidol—ABCB1—digestive system—stomach cancer	0.000248	0.0033	CbGeAlD
Haloperidol—ABCB1—bone marrow—stomach cancer	0.000228	0.00304	CbGeAlD
Haloperidol—ABCB1—endocrine gland—stomach cancer	0.000205	0.00272	CbGeAlD
Haloperidol—Weight increased—Epirubicin—stomach cancer	0.000202	0.00119	CcSEcCtD
Haloperidol—Weight decreased—Epirubicin—stomach cancer	0.0002	0.00118	CcSEcCtD
Haloperidol—Hyperglycaemia—Epirubicin—stomach cancer	0.0002	0.00118	CcSEcCtD
Haloperidol—Hepatobiliary disease—Methotrexate—stomach cancer	0.0002	0.00118	CcSEcCtD
Haloperidol—Vertigo—Capecitabine—stomach cancer	0.000199	0.00118	CcSEcCtD
Haloperidol—Hypersensitivity—Irinotecan—stomach cancer	0.000199	0.00118	CcSEcCtD
Haloperidol—Leukopenia—Capecitabine—stomach cancer	0.000198	0.00117	CcSEcCtD
Haloperidol—Convulsion—Docetaxel—stomach cancer	0.000198	0.00117	CcSEcCtD
Haloperidol—Hypertension—Docetaxel—stomach cancer	0.000198	0.00117	CcSEcCtD
Haloperidol—Drowsiness—Epirubicin—stomach cancer	0.000198	0.00117	CcSEcCtD
Haloperidol—Agranulocytosis—Methotrexate—stomach cancer	0.000197	0.00116	CcSEcCtD
Haloperidol—Pancytopenia—Doxorubicin—stomach cancer	0.000195	0.00115	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000193	0.00114	CcSEcCtD
Haloperidol—Jaundice—Epirubicin—stomach cancer	0.000193	0.00114	CcSEcCtD
Haloperidol—Neutropenia—Doxorubicin—stomach cancer	0.000192	0.00113	CcSEcCtD
Haloperidol—Hypertension—Capecitabine—stomach cancer	0.000191	0.00113	CcSEcCtD
Haloperidol—Hypersensitivity—Fluorouracil—stomach cancer	0.000191	0.00113	CcSEcCtD
Haloperidol—Dry mouth—Docetaxel—stomach cancer	0.000191	0.00113	CcSEcCtD
Haloperidol—Hepatitis—Methotrexate—stomach cancer	0.000189	0.00112	CcSEcCtD
Haloperidol—Confusional state—Docetaxel—stomach cancer	0.000188	0.00111	CcSEcCtD
Haloperidol—Anxiety—Capecitabine—stomach cancer	0.000188	0.00111	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000187	0.00111	CcSEcCtD
Haloperidol—Urinary tract disorder—Methotrexate—stomach cancer	0.000187	0.00111	CcSEcCtD
Haloperidol—Photosensitivity reaction—Doxorubicin—stomach cancer	0.000187	0.00111	CcSEcCtD
Haloperidol—Hepatobiliary disease—Epirubicin—stomach cancer	0.000187	0.0011	CcSEcCtD
Haloperidol—Anaphylactic shock—Docetaxel—stomach cancer	0.000187	0.0011	CcSEcCtD
Haloperidol—Oedema—Docetaxel—stomach cancer	0.000187	0.0011	CcSEcCtD
Haloperidol—Weight increased—Doxorubicin—stomach cancer	0.000187	0.0011	CcSEcCtD
Haloperidol—Urethral disorder—Methotrexate—stomach cancer	0.000186	0.0011	CcSEcCtD
Haloperidol—Weight decreased—Doxorubicin—stomach cancer	0.000185	0.0011	CcSEcCtD
Haloperidol—Hyperglycaemia—Doxorubicin—stomach cancer	0.000185	0.00109	CcSEcCtD
Haloperidol—Diarrhoea—Irinotecan—stomach cancer	0.000185	0.00109	CcSEcCtD
Haloperidol—ABCB1—liver—stomach cancer	0.000185	0.00246	CbGeAlD
Haloperidol—Dry mouth—Capecitabine—stomach cancer	0.000184	0.00109	CcSEcCtD
Haloperidol—Agranulocytosis—Epirubicin—stomach cancer	0.000184	0.00109	CcSEcCtD
Haloperidol—Nervous system disorder—Docetaxel—stomach cancer	0.000183	0.00108	CcSEcCtD
Haloperidol—Pruritus—Fluorouracil—stomach cancer	0.000183	0.00108	CcSEcCtD
Haloperidol—Thrombocytopenia—Docetaxel—stomach cancer	0.000183	0.00108	CcSEcCtD
Haloperidol—Drowsiness—Doxorubicin—stomach cancer	0.000183	0.00108	CcSEcCtD
Haloperidol—Visual impairment—Methotrexate—stomach cancer	0.000183	0.00108	CcSEcCtD
Haloperidol—Confusional state—Capecitabine—stomach cancer	0.000182	0.00108	CcSEcCtD
Haloperidol—Tachycardia—Docetaxel—stomach cancer	0.000182	0.00108	CcSEcCtD
Haloperidol—Skin disorder—Docetaxel—stomach cancer	0.000181	0.00107	CcSEcCtD
Haloperidol—Oedema—Capecitabine—stomach cancer	0.000181	0.00107	CcSEcCtD
Haloperidol—Dizziness—Irinotecan—stomach cancer	0.000179	0.00106	CcSEcCtD
Haloperidol—Jaundice—Doxorubicin—stomach cancer	0.000178	0.00105	CcSEcCtD
Haloperidol—Anorexia—Docetaxel—stomach cancer	0.000178	0.00105	CcSEcCtD
Haloperidol—Nervous system disorder—Capecitabine—stomach cancer	0.000177	0.00105	CcSEcCtD
Haloperidol—Hepatitis—Epirubicin—stomach cancer	0.000177	0.00105	CcSEcCtD
Haloperidol—Eye disorder—Methotrexate—stomach cancer	0.000177	0.00105	CcSEcCtD
Haloperidol—Diarrhoea—Fluorouracil—stomach cancer	0.000177	0.00105	CcSEcCtD
Haloperidol—Thrombocytopenia—Capecitabine—stomach cancer	0.000177	0.00105	CcSEcCtD
Haloperidol—Tachycardia—Capecitabine—stomach cancer	0.000176	0.00104	CcSEcCtD
Haloperidol—Cardiac disorder—Methotrexate—stomach cancer	0.000176	0.00104	CcSEcCtD
Haloperidol—Skin disorder—Capecitabine—stomach cancer	0.000176	0.00104	CcSEcCtD
Haloperidol—Urinary tract disorder—Epirubicin—stomach cancer	0.000175	0.00103	CcSEcCtD
Haloperidol—Hyperhidrosis—Capecitabine—stomach cancer	0.000175	0.00103	CcSEcCtD
Haloperidol—Hypotension—Docetaxel—stomach cancer	0.000175	0.00103	CcSEcCtD
Haloperidol—Connective tissue disorder—Epirubicin—stomach cancer	0.000174	0.00103	CcSEcCtD
Haloperidol—Urethral disorder—Epirubicin—stomach cancer	0.000174	0.00103	CcSEcCtD
Haloperidol—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000173	0.00102	CcSEcCtD
Haloperidol—Anorexia—Capecitabine—stomach cancer	0.000172	0.00102	CcSEcCtD
Haloperidol—Angiopathy—Methotrexate—stomach cancer	0.000172	0.00102	CcSEcCtD
Haloperidol—Vomiting—Irinotecan—stomach cancer	0.000172	0.00102	CcSEcCtD
Haloperidol—Immune system disorder—Methotrexate—stomach cancer	0.000171	0.00101	CcSEcCtD
Haloperidol—Dizziness—Fluorouracil—stomach cancer	0.000171	0.00101	CcSEcCtD
Haloperidol—Visual impairment—Epirubicin—stomach cancer	0.000171	0.00101	CcSEcCtD
Haloperidol—Mediastinal disorder—Methotrexate—stomach cancer	0.000171	0.00101	CcSEcCtD
Haloperidol—Agranulocytosis—Doxorubicin—stomach cancer	0.000171	0.00101	CcSEcCtD
Haloperidol—Rash—Irinotecan—stomach cancer	0.00017	0.00101	CcSEcCtD
Haloperidol—Dermatitis—Irinotecan—stomach cancer	0.00017	0.00101	CcSEcCtD
Haloperidol—Headache—Irinotecan—stomach cancer	0.000169	0.001	CcSEcCtD
Haloperidol—Hypotension—Capecitabine—stomach cancer	0.000169	0.000999	CcSEcCtD
Haloperidol—Insomnia—Docetaxel—stomach cancer	0.000169	0.000998	CcSEcCtD
Haloperidol—Alopecia—Methotrexate—stomach cancer	0.000167	0.000989	CcSEcCtD
Haloperidol—Dyspnoea—Docetaxel—stomach cancer	0.000167	0.000984	CcSEcCtD
Haloperidol—Somnolence—Docetaxel—stomach cancer	0.000166	0.000981	CcSEcCtD
Haloperidol—Mental disorder—Methotrexate—stomach cancer	0.000166	0.000981	CcSEcCtD
Haloperidol—Eye disorder—Epirubicin—stomach cancer	0.000166	0.000979	CcSEcCtD
Haloperidol—Malnutrition—Methotrexate—stomach cancer	0.000165	0.000975	CcSEcCtD
Haloperidol—Cardiac disorder—Epirubicin—stomach cancer	0.000165	0.000973	CcSEcCtD
Haloperidol—Vomiting—Fluorouracil—stomach cancer	0.000165	0.000972	CcSEcCtD
Haloperidol—Dyspepsia—Docetaxel—stomach cancer	0.000164	0.000972	CcSEcCtD
Haloperidol—Hepatitis—Doxorubicin—stomach cancer	0.000164	0.00097	CcSEcCtD
Haloperidol—Insomnia—Capecitabine—stomach cancer	0.000164	0.000967	CcSEcCtD
Haloperidol—Rash—Fluorouracil—stomach cancer	0.000163	0.000964	CcSEcCtD
Haloperidol—Dermatitis—Fluorouracil—stomach cancer	0.000163	0.000963	CcSEcCtD
Haloperidol—Decreased appetite—Docetaxel—stomach cancer	0.000162	0.000959	CcSEcCtD
Haloperidol—Headache—Fluorouracil—stomach cancer	0.000162	0.000958	CcSEcCtD
Haloperidol—Urinary tract disorder—Doxorubicin—stomach cancer	0.000162	0.000958	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000161	0.000953	CcSEcCtD
Haloperidol—Connective tissue disorder—Doxorubicin—stomach cancer	0.000161	0.000953	CcSEcCtD
Haloperidol—Dyspnoea—Capecitabine—stomach cancer	0.000161	0.000953	CcSEcCtD
Haloperidol—Angiopathy—Epirubicin—stomach cancer	0.000161	0.000951	CcSEcCtD
Haloperidol—Urethral disorder—Doxorubicin—stomach cancer	0.000161	0.00095	CcSEcCtD
Haloperidol—Nausea—Irinotecan—stomach cancer	0.00016	0.000948	CcSEcCtD
Haloperidol—Immune system disorder—Epirubicin—stomach cancer	0.00016	0.000947	CcSEcCtD
Haloperidol—Mediastinal disorder—Epirubicin—stomach cancer	0.00016	0.000944	CcSEcCtD
Haloperidol—Constipation—Docetaxel—stomach cancer	0.00016	0.000944	CcSEcCtD
Haloperidol—Dyspepsia—Capecitabine—stomach cancer	0.000159	0.000941	CcSEcCtD
Haloperidol—Visual impairment—Doxorubicin—stomach cancer	0.000158	0.000934	CcSEcCtD
Haloperidol—Decreased appetite—Capecitabine—stomach cancer	0.000157	0.000929	CcSEcCtD
Haloperidol—Alopecia—Epirubicin—stomach cancer	0.000157	0.000926	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000156	0.000923	CcSEcCtD
Haloperidol—Vision blurred—Methotrexate—stomach cancer	0.000155	0.000919	CcSEcCtD
Haloperidol—Mental disorder—Epirubicin—stomach cancer	0.000155	0.000918	CcSEcCtD
Haloperidol—Constipation—Capecitabine—stomach cancer	0.000155	0.000914	CcSEcCtD
Haloperidol—Malnutrition—Epirubicin—stomach cancer	0.000154	0.000912	CcSEcCtD
Haloperidol—Feeling abnormal—Docetaxel—stomach cancer	0.000154	0.00091	CcSEcCtD
Haloperidol—Nausea—Fluorouracil—stomach cancer	0.000154	0.000908	CcSEcCtD
Haloperidol—Eye disorder—Doxorubicin—stomach cancer	0.000153	0.000906	CcSEcCtD
Haloperidol—Anaemia—Methotrexate—stomach cancer	0.000152	0.000901	CcSEcCtD
Haloperidol—Cardiac disorder—Doxorubicin—stomach cancer	0.000152	0.0009	CcSEcCtD
Haloperidol—Feeling abnormal—Capecitabine—stomach cancer	0.000149	0.000881	CcSEcCtD
Haloperidol—Angiopathy—Doxorubicin—stomach cancer	0.000149	0.00088	CcSEcCtD
Haloperidol—Muscle spasms—Epirubicin—stomach cancer	0.000148	0.000877	CcSEcCtD
Haloperidol—Immune system disorder—Doxorubicin—stomach cancer	0.000148	0.000876	CcSEcCtD
Haloperidol—Vertigo—Methotrexate—stomach cancer	0.000148	0.000876	CcSEcCtD
Haloperidol—Mediastinal disorder—Doxorubicin—stomach cancer	0.000148	0.000874	CcSEcCtD
Haloperidol—Body temperature increased—Docetaxel—stomach cancer	0.000148	0.000873	CcSEcCtD
Haloperidol—Leukopenia—Methotrexate—stomach cancer	0.000148	0.000873	CcSEcCtD
Haloperidol—Vision blurred—Epirubicin—stomach cancer	0.000145	0.00086	CcSEcCtD
Haloperidol—Alopecia—Doxorubicin—stomach cancer	0.000145	0.000857	CcSEcCtD
Haloperidol—Mental disorder—Doxorubicin—stomach cancer	0.000144	0.000849	CcSEcCtD
Haloperidol—Urticaria—Capecitabine—stomach cancer	0.000144	0.000849	CcSEcCtD
Haloperidol—Body temperature increased—Capecitabine—stomach cancer	0.000143	0.000845	CcSEcCtD
Haloperidol—Convulsion—Methotrexate—stomach cancer	0.000143	0.000845	CcSEcCtD
Haloperidol—Malnutrition—Doxorubicin—stomach cancer	0.000143	0.000844	CcSEcCtD
Haloperidol—Anaemia—Epirubicin—stomach cancer	0.000143	0.000843	CcSEcCtD
Haloperidol—Agitation—Epirubicin—stomach cancer	0.000142	0.000838	CcSEcCtD
Haloperidol—ABCB1—lymph node—stomach cancer	0.000142	0.00188	CbGeAlD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000139	0.000824	CcSEcCtD
Haloperidol—Vertigo—Epirubicin—stomach cancer	0.000139	0.00082	CcSEcCtD
Haloperidol—Leukopenia—Epirubicin—stomach cancer	0.000138	0.000817	CcSEcCtD
Haloperidol—Hypersensitivity—Docetaxel—stomach cancer	0.000138	0.000813	CcSEcCtD
Haloperidol—Muscle spasms—Doxorubicin—stomach cancer	0.000137	0.000811	CcSEcCtD
Haloperidol—Confusional state—Methotrexate—stomach cancer	0.000136	0.000802	CcSEcCtD
Haloperidol—Anaphylactic shock—Methotrexate—stomach cancer	0.000135	0.000796	CcSEcCtD
Haloperidol—Vision blurred—Doxorubicin—stomach cancer	0.000135	0.000795	CcSEcCtD
Haloperidol—Convulsion—Epirubicin—stomach cancer	0.000134	0.00079	CcSEcCtD
Haloperidol—Hypertension—Epirubicin—stomach cancer	0.000133	0.000788	CcSEcCtD
Haloperidol—Hypersensitivity—Capecitabine—stomach cancer	0.000133	0.000787	CcSEcCtD
Haloperidol—Pruritus—Docetaxel—stomach cancer	0.000132	0.000781	CcSEcCtD
Haloperidol—Nervous system disorder—Methotrexate—stomach cancer	0.000132	0.00078	CcSEcCtD
Haloperidol—Anaemia—Doxorubicin—stomach cancer	0.000132	0.00078	CcSEcCtD
Haloperidol—Thrombocytopenia—Methotrexate—stomach cancer	0.000132	0.000779	CcSEcCtD
Haloperidol—Agitation—Doxorubicin—stomach cancer	0.000131	0.000776	CcSEcCtD
Haloperidol—Anxiety—Epirubicin—stomach cancer	0.000131	0.000774	CcSEcCtD
Haloperidol—Skin disorder—Methotrexate—stomach cancer	0.000131	0.000773	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000131	0.000771	CcSEcCtD
Haloperidol—Hyperhidrosis—Methotrexate—stomach cancer	0.00013	0.000769	CcSEcCtD
Haloperidol—Dry mouth—Epirubicin—stomach cancer	0.000129	0.00076	CcSEcCtD
Haloperidol—Vertigo—Doxorubicin—stomach cancer	0.000128	0.000758	CcSEcCtD
Haloperidol—Anorexia—Methotrexate—stomach cancer	0.000128	0.000758	CcSEcCtD
Haloperidol—Pruritus—Capecitabine—stomach cancer	0.000128	0.000756	CcSEcCtD
Haloperidol—Leukopenia—Doxorubicin—stomach cancer	0.000128	0.000756	CcSEcCtD
Haloperidol—Diarrhoea—Docetaxel—stomach cancer	0.000128	0.000755	CcSEcCtD
Haloperidol—Confusional state—Epirubicin—stomach cancer	0.000127	0.000751	CcSEcCtD
Haloperidol—Anaphylactic shock—Epirubicin—stomach cancer	0.000126	0.000744	CcSEcCtD
Haloperidol—Oedema—Epirubicin—stomach cancer	0.000126	0.000744	CcSEcCtD
Haloperidol—Hypotension—Methotrexate—stomach cancer	0.000126	0.000743	CcSEcCtD
Haloperidol—Convulsion—Doxorubicin—stomach cancer	0.000124	0.000731	CcSEcCtD
Haloperidol—Diarrhoea—Capecitabine—stomach cancer	0.000124	0.000731	CcSEcCtD
Haloperidol—Nervous system disorder—Epirubicin—stomach cancer	0.000124	0.00073	CcSEcCtD
Haloperidol—Dizziness—Docetaxel—stomach cancer	0.000124	0.00073	CcSEcCtD
Haloperidol—Thrombocytopenia—Epirubicin—stomach cancer	0.000123	0.000729	CcSEcCtD
Haloperidol—Hypertension—Doxorubicin—stomach cancer	0.000123	0.000729	CcSEcCtD
Haloperidol—Tachycardia—Epirubicin—stomach cancer	0.000123	0.000727	CcSEcCtD
Haloperidol—Skin disorder—Epirubicin—stomach cancer	0.000122	0.000723	CcSEcCtD
Haloperidol—Hyperhidrosis—Epirubicin—stomach cancer	0.000122	0.00072	CcSEcCtD
Haloperidol—Insomnia—Methotrexate—stomach cancer	0.000122	0.00072	CcSEcCtD
Haloperidol—Anxiety—Doxorubicin—stomach cancer	0.000121	0.000716	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000121	0.000714	CcSEcCtD
Haloperidol—Anorexia—Epirubicin—stomach cancer	0.00012	0.00071	CcSEcCtD
Haloperidol—Dyspnoea—Methotrexate—stomach cancer	0.00012	0.000709	CcSEcCtD
Haloperidol—Somnolence—Methotrexate—stomach cancer	0.00012	0.000707	CcSEcCtD
Haloperidol—Dizziness—Capecitabine—stomach cancer	0.00012	0.000707	CcSEcCtD
Haloperidol—Dry mouth—Doxorubicin—stomach cancer	0.000119	0.000703	CcSEcCtD
Haloperidol—Vomiting—Docetaxel—stomach cancer	0.000119	0.000702	CcSEcCtD
Haloperidol—Dyspepsia—Methotrexate—stomach cancer	0.000118	0.0007	CcSEcCtD
Haloperidol—Rash—Docetaxel—stomach cancer	0.000118	0.000696	CcSEcCtD
Haloperidol—Hypotension—Epirubicin—stomach cancer	0.000118	0.000696	CcSEcCtD
Haloperidol—Dermatitis—Docetaxel—stomach cancer	0.000118	0.000695	CcSEcCtD
Haloperidol—Confusional state—Doxorubicin—stomach cancer	0.000118	0.000695	CcSEcCtD
Haloperidol—Decreased appetite—Methotrexate—stomach cancer	0.000117	0.000692	CcSEcCtD
Haloperidol—Headache—Docetaxel—stomach cancer	0.000117	0.000691	CcSEcCtD
Haloperidol—Anaphylactic shock—Doxorubicin—stomach cancer	0.000117	0.000689	CcSEcCtD
Haloperidol—Oedema—Doxorubicin—stomach cancer	0.000117	0.000689	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000116	0.000687	CcSEcCtD
Haloperidol—Vomiting—Capecitabine—stomach cancer	0.000115	0.000679	CcSEcCtD
Haloperidol—Nervous system disorder—Doxorubicin—stomach cancer	0.000114	0.000676	CcSEcCtD
Haloperidol—Thrombocytopenia—Doxorubicin—stomach cancer	0.000114	0.000674	CcSEcCtD
Haloperidol—Rash—Capecitabine—stomach cancer	0.000114	0.000674	CcSEcCtD
Haloperidol—Insomnia—Epirubicin—stomach cancer	0.000114	0.000673	CcSEcCtD
Haloperidol—Dermatitis—Capecitabine—stomach cancer	0.000114	0.000673	CcSEcCtD
Haloperidol—Tachycardia—Doxorubicin—stomach cancer	0.000114	0.000672	CcSEcCtD
Haloperidol—Headache—Capecitabine—stomach cancer	0.000113	0.000669	CcSEcCtD
Haloperidol—Skin disorder—Doxorubicin—stomach cancer	0.000113	0.000669	CcSEcCtD
Haloperidol—Hyperhidrosis—Doxorubicin—stomach cancer	0.000113	0.000666	CcSEcCtD
Haloperidol—Dyspnoea—Epirubicin—stomach cancer	0.000112	0.000664	CcSEcCtD
Haloperidol—Somnolence—Epirubicin—stomach cancer	0.000112	0.000662	CcSEcCtD
Haloperidol—Anorexia—Doxorubicin—stomach cancer	0.000111	0.000657	CcSEcCtD
Haloperidol—Nausea—Docetaxel—stomach cancer	0.000111	0.000656	CcSEcCtD
Haloperidol—Feeling abnormal—Methotrexate—stomach cancer	0.000111	0.000656	CcSEcCtD
Haloperidol—Dyspepsia—Epirubicin—stomach cancer	0.000111	0.000655	CcSEcCtD
Haloperidol—Decreased appetite—Epirubicin—stomach cancer	0.00011	0.000647	CcSEcCtD
Haloperidol—Hypotension—Doxorubicin—stomach cancer	0.000109	0.000644	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000109	0.000643	CcSEcCtD
Haloperidol—Constipation—Epirubicin—stomach cancer	0.000108	0.000637	CcSEcCtD
Haloperidol—Nausea—Capecitabine—stomach cancer	0.000107	0.000635	CcSEcCtD
Haloperidol—Urticaria—Methotrexate—stomach cancer	0.000107	0.000632	CcSEcCtD
Haloperidol—Body temperature increased—Methotrexate—stomach cancer	0.000106	0.000629	CcSEcCtD
Haloperidol—Insomnia—Doxorubicin—stomach cancer	0.000105	0.000623	CcSEcCtD
Haloperidol—Dyspnoea—Doxorubicin—stomach cancer	0.000104	0.000614	CcSEcCtD
Haloperidol—Feeling abnormal—Epirubicin—stomach cancer	0.000104	0.000613	CcSEcCtD
Haloperidol—Somnolence—Doxorubicin—stomach cancer	0.000104	0.000612	CcSEcCtD
Haloperidol—Dyspepsia—Doxorubicin—stomach cancer	0.000103	0.000606	CcSEcCtD
Haloperidol—Decreased appetite—Doxorubicin—stomach cancer	0.000101	0.000599	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000101	0.000595	CcSEcCtD
Haloperidol—Urticaria—Epirubicin—stomach cancer	0.0001	0.000591	CcSEcCtD
Haloperidol—Constipation—Doxorubicin—stomach cancer	9.97e-05	0.000589	CcSEcCtD
Haloperidol—Body temperature increased—Epirubicin—stomach cancer	9.96e-05	0.000589	CcSEcCtD
Haloperidol—Hypersensitivity—Methotrexate—stomach cancer	9.92e-05	0.000586	CcSEcCtD
Haloperidol—Feeling abnormal—Doxorubicin—stomach cancer	9.61e-05	0.000568	CcSEcCtD
Haloperidol—Pruritus—Methotrexate—stomach cancer	9.52e-05	0.000563	CcSEcCtD
Haloperidol—Hypersensitivity—Epirubicin—stomach cancer	9.28e-05	0.000549	CcSEcCtD
Haloperidol—Urticaria—Doxorubicin—stomach cancer	9.26e-05	0.000547	CcSEcCtD
Haloperidol—Body temperature increased—Doxorubicin—stomach cancer	9.21e-05	0.000545	CcSEcCtD
Haloperidol—Diarrhoea—Methotrexate—stomach cancer	9.21e-05	0.000544	CcSEcCtD
Haloperidol—Pruritus—Epirubicin—stomach cancer	8.91e-05	0.000527	CcSEcCtD
Haloperidol—Dizziness—Methotrexate—stomach cancer	8.9e-05	0.000526	CcSEcCtD
Haloperidol—Diarrhoea—Epirubicin—stomach cancer	8.62e-05	0.000509	CcSEcCtD
Haloperidol—Hypersensitivity—Doxorubicin—stomach cancer	8.59e-05	0.000508	CcSEcCtD
Haloperidol—Vomiting—Methotrexate—stomach cancer	8.56e-05	0.000506	CcSEcCtD
Haloperidol—Rash—Methotrexate—stomach cancer	8.49e-05	0.000502	CcSEcCtD
Haloperidol—Dermatitis—Methotrexate—stomach cancer	8.48e-05	0.000501	CcSEcCtD
Haloperidol—Headache—Methotrexate—stomach cancer	8.43e-05	0.000498	CcSEcCtD
Haloperidol—Dizziness—Epirubicin—stomach cancer	8.33e-05	0.000492	CcSEcCtD
Haloperidol—Pruritus—Doxorubicin—stomach cancer	8.25e-05	0.000487	CcSEcCtD
Haloperidol—Vomiting—Epirubicin—stomach cancer	8.01e-05	0.000473	CcSEcCtD
Haloperidol—Nausea—Methotrexate—stomach cancer	8e-05	0.000473	CcSEcCtD
Haloperidol—Diarrhoea—Doxorubicin—stomach cancer	7.98e-05	0.000471	CcSEcCtD
Haloperidol—Rash—Epirubicin—stomach cancer	7.94e-05	0.000469	CcSEcCtD
Haloperidol—Dermatitis—Epirubicin—stomach cancer	7.94e-05	0.000469	CcSEcCtD
Haloperidol—Headache—Epirubicin—stomach cancer	7.89e-05	0.000466	CcSEcCtD
Haloperidol—Dizziness—Doxorubicin—stomach cancer	7.71e-05	0.000456	CcSEcCtD
Haloperidol—Nausea—Epirubicin—stomach cancer	7.48e-05	0.000442	CcSEcCtD
Haloperidol—Vomiting—Doxorubicin—stomach cancer	7.41e-05	0.000438	CcSEcCtD
Haloperidol—Rash—Doxorubicin—stomach cancer	7.35e-05	0.000434	CcSEcCtD
Haloperidol—Dermatitis—Doxorubicin—stomach cancer	7.34e-05	0.000434	CcSEcCtD
Haloperidol—Headache—Doxorubicin—stomach cancer	7.3e-05	0.000432	CcSEcCtD
Haloperidol—Nausea—Doxorubicin—stomach cancer	6.92e-05	0.000409	CcSEcCtD
Haloperidol—HTR2B—Signaling Pathways—CDKN1A—stomach cancer	4.51e-06	2.98e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GSTM1—stomach cancer	4.51e-06	2.98e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IL6R—stomach cancer	4.49e-06	2.97e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—IL6—stomach cancer	4.49e-06	2.96e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—AKR1C3—stomach cancer	4.49e-06	2.96e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—IL6—stomach cancer	4.43e-06	2.92e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IL6R—stomach cancer	4.42e-06	2.92e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—VEGFA—stomach cancer	4.42e-06	2.92e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IL6R—stomach cancer	4.41e-06	2.91e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—MAPK1—stomach cancer	4.41e-06	2.91e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—EGFR—stomach cancer	4.41e-06	2.91e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MAPK8—stomach cancer	4.4e-06	2.91e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CCND1—stomach cancer	4.4e-06	2.9e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—JUN—stomach cancer	4.39e-06	2.9e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—STAT3—stomach cancer	4.38e-06	2.89e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ENO1—stomach cancer	4.37e-06	2.89e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—MTHFR—stomach cancer	4.37e-06	2.88e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—MAPK1—stomach cancer	4.34e-06	2.87e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CCND1—stomach cancer	4.34e-06	2.86e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—EGFR—stomach cancer	4.34e-06	2.86e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—MAPK1—stomach cancer	4.33e-06	2.86e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—JUN—stomach cancer	4.33e-06	2.86e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PPARG—stomach cancer	4.33e-06	2.86e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—EGFR—stomach cancer	4.33e-06	2.86e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—VEGFA—stomach cancer	4.33e-06	2.86e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—STAT3—stomach cancer	4.29e-06	2.83e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ERCC2—stomach cancer	4.28e-06	2.82e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PPP2R1A—stomach cancer	4.27e-06	2.82e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MMP9—stomach cancer	4.27e-06	2.82e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—MTHFR—stomach cancer	4.27e-06	2.82e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—VEGFA—stomach cancer	4.26e-06	2.81e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CDKN1A—stomach cancer	4.25e-06	2.81e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ERCC2—stomach cancer	4.24e-06	2.8e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—STAT3—stomach cancer	4.22e-06	2.78e-05	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—PIK3CA—stomach cancer	4.21e-06	2.78e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MMP9—stomach cancer	4.21e-06	2.78e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SERPINE1—stomach cancer	4.21e-06	2.78e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CDKN1A—stomach cancer	4.2e-06	2.77e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GSTP1—stomach cancer	4.19e-06	2.77e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—MAPK3—stomach cancer	4.18e-06	2.76e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—KRAS—stomach cancer	4.17e-06	2.75e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MAPK8—stomach cancer	4.15e-06	2.74e-05	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—PIK3CA—stomach cancer	4.15e-06	2.74e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SERPINE1—stomach cancer	4.14e-06	2.73e-05	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—PIK3CA—stomach cancer	4.14e-06	2.73e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—HMOX1—stomach cancer	4.13e-06	2.73e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SERPINE1—stomach cancer	4.13e-06	2.73e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—ALB—stomach cancer	4.12e-06	2.72e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—KRAS—stomach cancer	4.1e-06	2.71e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MAPK8—stomach cancer	4.1e-06	2.7e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—MAPK3—stomach cancer	4.09e-06	2.7e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—KRAS—stomach cancer	4.09e-06	2.7e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—MYC—stomach cancer	4.07e-06	2.68e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—VEGFA—stomach cancer	4.07e-06	2.68e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—RHOA—stomach cancer	4.06e-06	2.68e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CAV1—stomach cancer	4.03e-06	2.66e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—MAPK3—stomach cancer	4.03e-06	2.66e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—STAT3—stomach cancer	4.03e-06	2.66e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—APOA1—stomach cancer	4.02e-06	2.65e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—MTHFR—stomach cancer	4.02e-06	2.65e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NOS3—stomach cancer	4.02e-06	2.65e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—RHOA—stomach cancer	3.99e-06	2.64e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—RHOA—stomach cancer	3.99e-06	2.63e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—MTHFR—stomach cancer	3.98e-06	2.63e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—MYC—stomach cancer	3.98e-06	2.63e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—MAPK1—stomach cancer	3.98e-06	2.63e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—EGFR—stomach cancer	3.98e-06	2.63e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NOS3—stomach cancer	3.95e-06	2.61e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NOS3—stomach cancer	3.95e-06	2.6e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—NOS3—stomach cancer	3.94e-06	2.6e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CAV1—stomach cancer	3.93e-06	2.6e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—APOA1—stomach cancer	3.93e-06	2.59e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—MYC—stomach cancer	3.92e-06	2.59e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—TYMS—stomach cancer	3.9e-06	2.57e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—MAPK1—stomach cancer	3.9e-06	2.57e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—EGFR—stomach cancer	3.9e-06	2.57e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—ALB—stomach cancer	3.89e-06	2.57e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CD44—stomach cancer	3.88e-06	2.56e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GSTM1—stomach cancer	3.85e-06	2.54e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.85e-06	2.54e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MAPK3—stomach cancer	3.85e-06	2.54e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—VEGFA—stomach cancer	3.83e-06	2.53e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—MAPK1—stomach cancer	3.83e-06	2.53e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—EGFR—stomach cancer	3.83e-06	2.53e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—PIK3CA—stomach cancer	3.83e-06	2.53e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—STAT3—stomach cancer	3.8e-06	2.51e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—VEGFA—stomach cancer	3.78e-06	2.5e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—PIK3CA—stomach cancer	3.77e-06	2.49e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—ERBB2—stomach cancer	3.76e-06	2.48e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—PIK3CA—stomach cancer	3.76e-06	2.48e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—KRAS—stomach cancer	3.76e-06	2.48e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—STAT3—stomach cancer	3.75e-06	2.47e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MYC—stomach cancer	3.74e-06	2.47e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—NOS3—stomach cancer	3.72e-06	2.46e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CAV1—stomach cancer	3.71e-06	2.45e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—APOA1—stomach cancer	3.7e-06	2.44e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—ERBB2—stomach cancer	3.7e-06	2.44e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—ERBB2—stomach cancer	3.69e-06	2.44e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—KRAS—stomach cancer	3.68e-06	2.43e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CAV1—stomach cancer	3.68e-06	2.43e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—APOA1—stomach cancer	3.67e-06	2.42e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MAPK1—stomach cancer	3.66e-06	2.42e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—EGFR—stomach cancer	3.66e-06	2.42e-05	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PIK3CA—stomach cancer	3.65e-06	2.41e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MAPK3—stomach cancer	3.63e-06	2.39e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ERCC2—stomach cancer	3.62e-06	2.39e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—KRAS—stomach cancer	3.62e-06	2.39e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PTGS2—stomach cancer	3.61e-06	2.38e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MAPK3—stomach cancer	3.58e-06	2.36e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CXCL8—stomach cancer	3.56e-06	2.35e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PPARG—stomach cancer	3.54e-06	2.34e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—HRAS—stomach cancer	3.54e-06	2.34e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MYC—stomach cancer	3.53e-06	2.33e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.51e-06	2.32e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CXCL8—stomach cancer	3.51e-06	2.32e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CXCL8—stomach cancer	3.5e-06	2.31e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—HRAS—stomach cancer	3.48e-06	2.3e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CDKN1B—stomach cancer	3.48e-06	2.3e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MYC—stomach cancer	3.48e-06	2.3e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—HRAS—stomach cancer	3.48e-06	2.3e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PPARG—stomach cancer	3.46e-06	2.28e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—KRAS—stomach cancer	3.46e-06	2.28e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—PIK3CA—stomach cancer	3.45e-06	2.28e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MAPK1—stomach cancer	3.45e-06	2.28e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—EGFR—stomach cancer	3.45e-06	2.28e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CDKN1B—stomach cancer	3.42e-06	2.26e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CDKN1B—stomach cancer	3.42e-06	2.26e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PTGS2—stomach cancer	3.41e-06	2.25e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MAPK1—stomach cancer	3.41e-06	2.25e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—MTHFR—stomach cancer	3.4e-06	2.25e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—EGFR—stomach cancer	3.4e-06	2.25e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—IL6—stomach cancer	3.39e-06	2.24e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—PIK3CA—stomach cancer	3.38e-06	2.23e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TP53—stomach cancer	3.34e-06	2.2e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—IL6—stomach cancer	3.33e-06	2.2e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—IL6—stomach cancer	3.33e-06	2.2e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—PIK3CA—stomach cancer	3.33e-06	2.2e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CCND1—stomach cancer	3.32e-06	2.19e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—JUN—stomach cancer	3.31e-06	2.19e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PPP2R1A—stomach cancer	3.3e-06	2.18e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TP53—stomach cancer	3.27e-06	2.16e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CCND1—stomach cancer	3.27e-06	2.16e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—JUN—stomach cancer	3.26e-06	2.15e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CCND1—stomach cancer	3.26e-06	2.15e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—KRAS—stomach cancer	3.26e-06	2.15e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PPARG—stomach cancer	3.26e-06	2.15e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—JUN—stomach cancer	3.25e-06	2.15e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GSTP1—stomach cancer	3.24e-06	2.14e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PPARG—stomach cancer	3.23e-06	2.13e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MMP9—stomach cancer	3.22e-06	2.13e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TP53—stomach cancer	3.22e-06	2.12e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—KRAS—stomach cancer	3.22e-06	2.12e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CDKN1A—stomach cancer	3.21e-06	2.12e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—HRAS—stomach cancer	3.19e-06	2.11e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—HMOX1—stomach cancer	3.19e-06	2.11e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ALB—stomach cancer	3.19e-06	2.1e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—PIK3CA—stomach cancer	3.18e-06	2.1e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MMP9—stomach cancer	3.17e-06	2.09e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MMP9—stomach cancer	3.17e-06	2.09e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	3.16e-06	2.09e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CDKN1A—stomach cancer	3.15e-06	2.08e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CAV1—stomach cancer	3.14e-06	2.07e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MAPK8—stomach cancer	3.14e-06	2.07e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—APOA1—stomach cancer	3.13e-06	2.07e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—HRAS—stomach cancer	3.13e-06	2.06e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ALB—stomach cancer	3.11e-06	2.05e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MAPK8—stomach cancer	3.09e-06	2.04e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MAPK8—stomach cancer	3.08e-06	2.03e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—HRAS—stomach cancer	3.08e-06	2.03e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TP53—stomach cancer	3.07e-06	2.03e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PIK3CA—stomach cancer	3.07e-06	2.03e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IL6—stomach cancer	3.06e-06	2.02e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—NOS3—stomach cancer	3.05e-06	2.01e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—TYMS—stomach cancer	3.01e-06	1.99e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3e-06	1.98e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—PIK3CA—stomach cancer	2.99e-06	1.98e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IL6—stomach cancer	2.99e-06	1.98e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—NOS3—stomach cancer	2.97e-06	1.96e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GSTM1—stomach cancer	2.97e-06	1.96e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—PIK3CA—stomach cancer	2.95e-06	1.95e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IL6—stomach cancer	2.95e-06	1.94e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—HRAS—stomach cancer	2.94e-06	1.94e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ALB—stomach cancer	2.93e-06	1.93e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ALB—stomach cancer	2.91e-06	1.92e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TP53—stomach cancer	2.9e-06	1.91e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—VEGFA—stomach cancer	2.89e-06	1.91e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—STAT3—stomach cancer	2.87e-06	1.89e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TP53—stomach cancer	2.86e-06	1.89e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—VEGFA—stomach cancer	2.85e-06	1.88e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—VEGFA—stomach cancer	2.84e-06	1.88e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—STAT3—stomach cancer	2.82e-06	1.86e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—STAT3—stomach cancer	2.81e-06	1.86e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IL6—stomach cancer	2.81e-06	1.86e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—NOS3—stomach cancer	2.8e-06	1.85e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ERCC2—stomach cancer	2.8e-06	1.85e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PTGS2—stomach cancer	2.79e-06	1.84e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—NOS3—stomach cancer	2.78e-06	1.83e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—HRAS—stomach cancer	2.77e-06	1.83e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PPARG—stomach cancer	2.76e-06	1.82e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MAPK3—stomach cancer	2.74e-06	1.81e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—HRAS—stomach cancer	2.73e-06	1.8e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PTGS2—stomach cancer	2.72e-06	1.8e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MAPK3—stomach cancer	2.69e-06	1.78e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MAPK3—stomach cancer	2.69e-06	1.77e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MYC—stomach cancer	2.66e-06	1.76e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IL6—stomach cancer	2.65e-06	1.75e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—MTHFR—stomach cancer	2.63e-06	1.73e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MYC—stomach cancer	2.62e-06	1.73e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IL6—stomach cancer	2.62e-06	1.73e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MYC—stomach cancer	2.62e-06	1.73e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MAPK1—stomach cancer	2.61e-06	1.72e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—EGFR—stomach cancer	2.61e-06	1.72e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MAPK1—stomach cancer	2.56e-06	1.69e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PTGS2—stomach cancer	2.56e-06	1.69e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—EGFR—stomach cancer	2.56e-06	1.69e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MAPK1—stomach cancer	2.56e-06	1.69e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—EGFR—stomach cancer	2.56e-06	1.69e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PTGS2—stomach cancer	2.54e-06	1.68e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ALB—stomach cancer	2.48e-06	1.64e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—KRAS—stomach cancer	2.46e-06	1.62e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CAV1—stomach cancer	2.42e-06	1.6e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—KRAS—stomach cancer	2.42e-06	1.6e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—APOA1—stomach cancer	2.42e-06	1.6e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—KRAS—stomach cancer	2.42e-06	1.6e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—NOS3—stomach cancer	2.37e-06	1.57e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PIK3CA—stomach cancer	2.26e-06	1.49e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	2.22e-06	1.47e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PIK3CA—stomach cancer	2.22e-06	1.47e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PIK3CA—stomach cancer	2.22e-06	1.46e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TP53—stomach cancer	2.19e-06	1.44e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PTGS2—stomach cancer	2.17e-06	1.43e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TP53—stomach cancer	2.15e-06	1.42e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TP53—stomach cancer	2.15e-06	1.42e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PPARG—stomach cancer	2.13e-06	1.41e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PIK3CA—stomach cancer	2.1e-06	1.38e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—HRAS—stomach cancer	2.09e-06	1.38e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—HRAS—stomach cancer	2.06e-06	1.36e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—HRAS—stomach cancer	2.05e-06	1.36e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IL6—stomach cancer	2e-06	1.32e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IL6—stomach cancer	1.97e-06	1.3e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IL6—stomach cancer	1.97e-06	1.3e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ALB—stomach cancer	1.92e-06	1.26e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—NOS3—stomach cancer	1.83e-06	1.21e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PIK3CA—stomach cancer	1.71e-06	1.13e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PTGS2—stomach cancer	1.68e-06	1.11e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PIK3CA—stomach cancer	1.67e-06	1.1e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.58e-06	1.04e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.56e-06	1.03e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.34e-06	8.82e-06	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.03e-06	6.81e-06	CbGpPWpGaD
